These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9532228)

  • 21. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
    Foster TS
    Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biologic properties of lipoic acid].
    Bilska A; Włodek L
    Postepy Hig Med Dosw; 2002; 56(2):201-19. PubMed ID: 12107963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetic neuropathy].
    Klein W
    Dtsch Med J; 1969 Apr; 20(8):268-70. PubMed ID: 4920138
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of α-lipoic acid in diabetic neuropathy.
    Papanas N; Ziegler D
    Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. alpha-Lipoic acid in NIDDM patients with cardiac autonomic neuropathy.
    Köbberling J; Hompesch M
    Diabetes Care; 1997 Dec; 20(12):1918-20. PubMed ID: 9405919
    [No Abstract]   [Full Text] [Related]  

  • 27. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polyneuropathy--therapy].
    Meyer FP
    Dtsch Med Wochenschr; 2003 Mar; 128(11):572; author reply 572. PubMed ID: 12635035
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy].
    Winkler G; Kempler P
    Orv Hetil; 2010 Jun; 151(24):971-81. PubMed ID: 20519180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    He S; Pan YN; Zhang ZY
    Diabetes Res Clin Pract; 2014 Sep; 105(3):e9. PubMed ID: 25052901
    [No Abstract]   [Full Text] [Related]  

  • 32. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    He F; Zhang Y; Sun L
    Diabetes Res Clin Pract; 2014 May; 104(2):e33. PubMed ID: 24602352
    [No Abstract]   [Full Text] [Related]  

  • 33. Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats.
    Gouty S; Regalia J; Cai F; Helke CJ
    Auton Neurosci; 2003 Oct; 108(1-2):32-44. PubMed ID: 14614962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
    Ziegler D; Gries FA
    Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent antioxidant improves diabetic nerve damage.
    Mayo Clin Womens Healthsource; 2003 Oct; 7(10):3. PubMed ID: 14528176
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Li MX; Wang Y; Wang Y
    Neurosci Lett; 2015 May; 594():23-9. PubMed ID: 25800109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structural and functional condition of the left ventricle in patients with type 2 diabetes mellitus complicated with diabetic autonomic neuropathy].
    Sadykova HG; Nazhmutdinova DK
    Lik Sprava; 2009; (1-2):22-8. PubMed ID: 19953987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
    Strokov IA; Phokina AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic neuropathy: clinical and experimental progress in its pathogenesis and treatment].
    Maeda K; Yasuda H
    Nihon Rinsho; 1999 Mar; 57(3):578-83. PubMed ID: 10199137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.
    Agathos E; Tentolouris A; Eleftheriadou I; Katsaouni P; Nemtzas I; Petrou A; Papanikolaou C; Tentolouris N
    J Int Med Res; 2018 May; 46(5):1779-1790. PubMed ID: 29517942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.